Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiepileptic Efficacy and Safety”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Large-scale testing (Phase 3)WithdrawnNCT05814523
What this trial is testing

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Who this might be right for
Refractory Status Epilepticus
Marinus Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00603473
What this trial is testing

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 92
Testing effectiveness (Phase 2)Ended earlyNCT00689585
What this trial is testing

Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)

Who this might be right for
Complex Regional Pain Syndromes
McGill University Health Centre/Research Institute of the McGill University Health Centre 4
Testing effectiveness (Phase 2)Ended earlyNCT00290771
What this trial is testing

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Recurrent Glioblastoma Multiforme (GBM)
Novartis 231
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Post-approval studies (Phase 4)Study completedNCT00438451
What this trial is testing

Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs

Who this might be right for
Focal Epilepsy
Johannes Gutenberg University Mainz 361
Large-scale testing (Phase 3)Study completedNCT00522275
What this trial is testing

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Who this might be right for
Partial Epilepsies
UCB BIOSCIENCES, Inc. 308
Large-scale testing (Phase 3)Study completedNCT00035802
What this trial is testing

Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Large-scale testing (Phase 3)Study completedNCT00280696
What this trial is testing

Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Japan Co. Ltd. 352
Large-scale testing (Phase 3)Study completedNCT00236418
What this trial is testing

The Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Large-scale testing (Phase 3)Ended earlyNCT04320940
What this trial is testing

Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures

Who this might be right for
Epilepsy, Benign Neonatal
NEMA Research, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT02229123
What this trial is testing

Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study

Who this might be right for
Neonatal Seizures
University Hospital, Tours 18
Large-scale testing (Phase 3)Study completedNCT00210782
What this trial is testing

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Who this might be right for
Epilepsy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262
Testing effectiveness (Phase 2)Study completedNCT01147003
What this trial is testing

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Who this might be right for
Partial Onset Seizures
Novartis 93
Post-approval studies (Phase 4)UnknownNCT05697614
What this trial is testing

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

Who this might be right for
Drug Resistant Epilepsy
Dr Cipto Mangunkusumo General Hospital 100
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Large-scale testing (Phase 3)Study completedNCT00236717
What this trial is testing

The Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 865
Post-approval studies (Phase 4)Study completedNCT01235403
What this trial is testing

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

Who this might be right for
Partial Epilepsies
UCB Pharma 100
Load More Results